scholarly journals Heller's myotomy and pneumatic dilatation in the treatment of achalasia: a population-based case-control study assessing long-term quality of life

2015 ◽  
pp. n/a-n/a
Author(s):  
R. T. Gray ◽  
H. G. Coleman ◽  
K. W. Lau ◽  
C. McCaughey ◽  
P. V. Coyle ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Pneumatic Dilatation ◽  
Heller’S Myotomy ◽  
Heller's Myotomy ◽  
Control Study

Self-Reported Skin Morbidities and Health-Related Quality of Life: A Population-Based Nested Case-Control Study

Dermatology ◽  
2014 ◽  
Vol 228 (3) ◽  
pp. 261-268 ◽  
Author(s):  
G.R. Vinding ◽  
K.M. Knudsen ◽  
C. Ellervik ◽  
A.B. Olesen ◽  
G.B.E. Jemec
Keyword(s):  
Quality Of Life ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Nested Case Control ◽  
Control Study

Migraine, quality of life, and depression: A population-based case-control study

Neurology ◽  
2000 ◽  
Vol 55 (5) ◽  
pp. 629-635 ◽  
Author(s):  
R. B. Lipton ◽  
S. W. Hamelsky ◽  
K. B. Kolodner ◽  
T. J. Steiner ◽  
W. F. Stewart
Keyword(s):  
Quality Of Life ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Long-term impact of intrauterine fetal death on quality of life and depression: a case–control study

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Ida Kathrine Gravensteen ◽  
Linda Bjørk Helgadottir ◽  
Eva-Marie Jacobsen ◽  
Per Morten Sandset ◽  
Øivind Ekeberg
Keyword(s):  
Quality Of Life ◽  
Fetal Death ◽  
Case Control Study ◽  
Case Control ◽  
Intrauterine Fetal Death ◽  
Long Term Impact ◽  
Control Study

scholarly journals AMEND study protocol: a case–control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults

BMJ Open ◽  
2019 ◽  
Vol 9 (12) ◽  
pp. e032583
Author(s):  
Helen Marshall ◽  
Mark McMillan ◽  
Bing Wang ◽  
Robert Booy ◽  
Hossein Afzali ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Young Adults ◽  
Outcome Measures ◽  
Meningococcal Disease ◽  
Case Control Study ◽  
Case Control ◽  
Invasive Meningococcal Disease ◽  
Control Study

IntroductionInvasive meningococcal disease (IMD) primarily causes disease in young children and adolescents and can cause long-term disability. Many countries are considering implementation of meningococcal B and/or meningococcal ACWY vaccines to control meningococcal disease. Estimating the cost-effectiveness of meningococcal vaccine programme is hampered due to a lack of good quality costing and burden of disease data. This study aims to address this evidence gap by assessing the clinical, physical, neurocognitive, economic and societal impact of IMD on adolescents and young adults.Methods and analysisA case–control study of 64 participants with confirmed IMD (15–24 years 11 months at time of disease) and 64 control participants (17–34 years 11 months) will be conducted in Australia from 2016 to 2020. All participants will undergo a neurocognitive assessment, full medical examination, pure tone audiometry assessment and complete quality of life and behavioural questionnaires. Meningococcal cases will be assessed 2–10 years posthospitalisation and a subset of cases will be interviewed to explore in depth their experiences of IMD and its impact on their life. Primary outcome measures include general intellectual functioning from the Wechsler Adult Intelligence Scale and overall quality of life from the Health Utilities Index. Secondary outcome measures include academic achievement, executive functioning, behaviour, hearing, psychological and physical functioning. Outcome measures will be compared between cases and controls using independent t-tests or ORs, or if any significant confounders are identified, adjusted analyses (analysis of covariance or adjusted ORs) will be conducted. Thematic analysis will be used to analyse transcribed interviews and a costing model will be used to project lifetime costs.Ethics and disseminationThe Adolescent MENingococcal Disease (AMEND) study has been approved by the Human Research Ethics Committee of the Women’s and Children’s Health Network (HREC/14/WCHN/024). The results will be disseminated via peer-reviewed publications, conference presentations, study participants, and meningococcal and meningitis foundations.Trial registration numberNCT03798574.

Sign in / Sign up

Export Citation Format

Share Document